Powell and Warsh A Historic Fed Coexistence Raises Questions About Policy Direction UnRetirement Trend Accelerates as Older Americans Rejoin Workforce for Financial Security Roth Capital Maintains Its Stance on T1 Energy Following Internal Discussion Trump Pressures Bank of America and JPMorgan Over Claims of Conservative Discrimination Novartis Upgrades FullYear Outlook on Strong Operational Performance Irans Potential Tariffs on Hormuz Internet Cables Could Raise Costs for Europe ETON Q1 2026 Earnings EPS Misses Estimates Amid Operational Challenges ELS Q1 2026 Earnings Modest EPS Beat Amid Stable Operating Performance Braze Inc Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction UZF Q1 2026 Earnings Strong EPS Beat Signals Operational Efficiency Winmark Corporation WINA Q1 2026 Earnings EPS Misses Estimates Amid Margin Headwinds BlackRock Q1 2026 Earnings Strong EPS Beat Driven by Robust Fee Income and Asset Growth Neuronetics STIM Rallies 2 as Shares Test Key Resistance Levels Pacific Biosciences Up 238 Testing Resistance Amid Sector Rotation NCR Voyix VYX Gains 24 as Shares Test Key Levels Nexstar Media Group NXST Edges Higher as Stock Consolidates Near Key Resistance Nurix Therapeutics NRIX Edges Higher as Biotech Sector Focus Intensifies Key Levels in Play Morgan Stanley Adjusts Palo Alto Networks PANW Price Target Amid Shifting Cybersecurity Demand Trends CSIQ Q1 2026 Earnings NarrowerThanExpected Loss Shows Cost Discipline Amid Solar Market Challenges Wolfspeed Surges Over 4 as Bullish Momentum Builds PTON Q1 2026 Earnings EPS Misses Estimates Shares Edge Higher Amid Operational Updates GRWG Q1 2026 Earnings Narrow EPS Beat Highlights Cost Discipline Amidst Market Challenges Actinium Pharmaceuticals ATNM Q1 2026 Earnings Narrower Loss Beats Expectations as Development Pipeline Advances BayCom Corp Q1 2026 Earnings EPS Smashes Estimates by 226 but Shares Slip BUSE Q1 2026 Earnings EPS Beat by 132 with Strong Core Performance CPS Q1 2026 Earnings Earnings Miss Estimates Significantly as EPS Falls Short Damora Therapeutics Q1 2026 Earnings WiderThanExpected Loss Despite Stock Gain